查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600916

高流量氧氣鼻管市場：按組件、適應症和最終用戶分類 - 全球預測 2025-2030

High-flow Nasal Cannula Market by Component (Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit), Indication (Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

高流量氧氣鼻管市場2023年估值為31.1億美元，預計2024年將達33.8億美元，複合年成長率為9.17%，預計到2030年將達到57.6億美元。

高流量氧氣鼻管(HFNC) 是醫療設備，旨在以比標準氧氣鼻管更高的流量提供氧氣療法。該系統主要用於治療患有呼吸系統疾病的患者，其中增強供氧和改善濕化非常重要。其範圍包括監測氧氣輸送和改善重症加護環境中患者的舒適度，特別是呼吸困難且需要補充氧氣的​​新生兒、兒童和成人患者。由於慢性阻塞性肺病、肺炎等呼吸系統疾病的盛行率不斷上升，以及最近因 COVID-19 造成的激增，對 HFNC 系統的需求正在增加。應用範圍包括醫院、診所和家庭環境，最終用戶包括醫療機構和需要長期氧氣療法的患者。

主要市場統計
基準年[2023] 31.1億美元
預測年份 [2024] 33.8億美元
預測年份 [2030] 57.6億美元
複合年成長率（%） 9.17%

醫療技術的進步、對以患者為中心的護理的日益重視、人口老齡化以及全球住院患者數量的增加推動了 HFNC 市場的發展，從而刺激了對高效呼吸支持設備的需求。最近的機會來自於新興市場的認知和採用的提高、研發活動的增加以及人工智慧的整合以更準確地監測患者參數。然而，設備成本高、缺乏適當的報銷政策以及替代治療解決方案的存在等因素帶來了挑戰。新興市場的預算限制和影響創新產品上市時間的監管障礙也可能阻礙市場成長。

創新包括小型化設備以遠端醫療功能以及開發為個人化護理提供即時資料分析的智慧監控系統。將環保材料融入設備製造並探索穿戴式技術以實現無縫居家照護也提供了成長潛力。了解市場的動態本質，市場參與企業正在投資開發具有成本效益的先進 HFNC 系統，形成策略聯盟以擴展到開拓的地區，並擴大他們的醫療保健。透過適應不斷變化的醫療保健政策和患者需求，公司可以有效地利用 HFNC 市場即將出現的機會。

市場動態：快速發展的高流量氧氣鼻管市場的關鍵市場洞察

高流量氧氣鼻管市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 急性呼吸衰竭和睡眠呼吸中止症的盛行率增加
    • 增加 HFNC 在小兒支氣管炎和肺炎治療的使用
    • 居家照護中對非侵入性通氣和持續性呼吸道正壓的需求不斷增加
  • 市場限制因素
    • 與傳統插管相比高成本
  • 市場機會
    • 高流量氧氣鼻管的技術進步
    • 支持商業化的有利法規結構
  • 市場挑戰
    • 與不受監控地使用高流量氧氣鼻管相關的方式和併發症

波特五力：駕馭高流量氧氣鼻管市場的策略工具

波特的五力框架是了解高流量氧氣鼻管市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解高流量氧氣鼻管市場的外部影響

外部宏觀環境因素在塑造高流量氧氣鼻管市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解高流量氧氣鼻管市場的競爭格局

高流量氧氣鼻管市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣高流量氧氣鼻管市場供應商的績效評估

FPNV 定位矩陣是評估高流量氧氣鼻管市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 急性呼吸衰竭和睡眠呼吸中止症的盛行率增加
      • 增加 HFNC 在小兒支氣管炎和肺炎治療的使用
      • 居家照護環境中對非侵入性通氣和持續性呼吸道正壓的需求不斷增加
    • 抑制因素
      • 與傳統插管相比相對昂貴
    • 機會
      • 高流量氧氣鼻管的技術進步
      • 支持商業化的有利法規結構
    • 任務
      • 與無人監督使用高流量氧氣鼻管相關的方式和併發症
  • 市場區隔分析
    • 組件：大量採用空氣氧氣混合器，提供精確調節氧氣水平的關鍵能力
    • 最終用戶：高流量氧氣鼻管擴大在醫院中使用，以支持廣泛的患者和臨床場景。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章高流量氧氣鼻管市場：依組成部分

  • 主動加濕器
  • 空氣氧氣混合機
  • 加熱進氣迴路
  • 氧氣鼻管

第7章依適應症分類的高流量氧氣鼻管市場

  • 急性心臟衰竭
  • 急性呼吸衰竭
  • 支氣管擴張
  • 一氧化碳毒性
  • 慢性阻塞性肺病

第8章高流量氧氣鼻管市場：依最終用戶分類

  • 門診治療中心
  • 醫院
  • 長期照護中心

第9章北美及南美高流量氧氣鼻管市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區高流量氧氣鼻管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲高流量氧氣鼻管市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 新的細支氣管炎試驗啟動，為嬰兒提供最佳呼吸支持
    • Teresa 的 Bonhawa Flow氧氣療法系統獲得 FDA核准
    • Mercy Flight 為患有呼吸道疾病的高風險患者實施高流量氧氣鼻管

公司名單

  • SunMed, LLC
  • Flexicare（Group）Limited
  • ResMed, Inc.
  • Armstrong Medical Limited
  • ICU Medical, Inc.
  • Fairmont Medical Products Pty Ltd.
  • Vapotherm, Inc.
  • Masimo Corporation
  • Dragerwerk AG & Co. KGaA
  • BMC Medical Co., Ltd.
  • Heka Medicals India Private Limited
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Corporation Limited
  • Well Lead Medical Co., Ltd.
  • Vyaire Medical, Inc.
  • Narang Medical Limited
  • Teleflex Incorporated
  • MEKICS Co., Ltd.
  • Great Group Medical Co., Ltd.
  • Allied Medical Limited
  • Guangdong Pigeon Medical Apparatus Co.,Ltd.
  • Hamilton Medical AG
  • Synergy Intact Private Limited
  • nice Neotech Medical Systems Pvt. Ltd.
  • Sterimed Group
Product Code: MRR-437E9896A57C

The High-flow Nasal Cannula Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 9.17%, to USD 5.76 billion by 2030.

The high-flow nasal cannula (HFNC) is a medical device designed for delivering oxygen therapy at a higher flow rate than standard nasal cannulas. This system is primarily used in the treatment of patients with respiratory diseases where enhanced oxygen delivery and improved humidification are critical. The scope includes monitoring oxygen delivery in critical care settings and improving patient comfort, particularly in neonatal, pediatric, and adult patients suffering from respiratory distress and requiring supplemental oxygen. The necessity for HFNC systems has grown due to an increased prevalence of respiratory conditions such as COPD, pneumonia, and recent surge due to COVID-19. Applications are broadly in hospitals, clinics, and home settings, with end-users including healthcare facilities and patients requiring long-term oxygen therapy.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.76 billion
CAGR (%) 9.17%

The HFNC market is being driven by advancements in medical technology, a heightened emphasis on patient-centric care, the aging population, and increased hospital admissions globally, which spur the demand for efficient breathing assistance devices. Recent opportunities arise from growing awareness and adoption in emerging markets, enhanced research and development activities, and the integration of artificial intelligence to monitor patient parameters more accurately. However, factors like high equipment costs, lack of adequate reimbursement policies, and the presence of alternative therapeutic solutions pose challenges. Market growth could be hampered by budget constraints in developing regions and regulatory hurdles impacting the time-to-market for innovative products.

Innovation scopes include the miniaturization of devices for improved portability, expanding telehealth capabilities, and the development of smart monitoring systems that deliver real-time data analytics for personalized care. Incorporating eco-friendly materials in device manufacturing and exploring wearable technologies for seamless home care also offer growth potential. Understanding the dynamic nature of the market, businesses should invest in creating cost-effective yet advanced HFNC systems, form strategic alliances to penetrate untapped regions, and actively participate in healthcare tech exhibitions to showcase innovation. By aligning with evolving healthcare policies and patient needs, companies can effectively harness upcoming opportunities in the HFNC market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High-flow Nasal Cannula Market

The High-flow Nasal Cannula Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
    • Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
    • Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
  • Market Restraints
    • Relatively High Cost Compared to Traditional Cannula
  • Market Opportunities
    • Technological Advancements in High-Flow Nasal Cannula
    • Favorable Regulatory Framework Supporting Commercialization
  • Market Challenges
    • Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula

Porter's Five Forces: A Strategic Tool for Navigating the High-flow Nasal Cannula Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High-flow Nasal Cannula Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High-flow Nasal Cannula Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High-flow Nasal Cannula Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High-flow Nasal Cannula Market

A detailed market share analysis in the High-flow Nasal Cannula Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High-flow Nasal Cannula Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High-flow Nasal Cannula Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the High-flow Nasal Cannula Market, highlighting leading vendors and their innovative profiles. These include SunMed, LLC, Flexicare (Group) Limited, ResMed, Inc., Armstrong Medical Limited, ICU Medical, Inc., Fairmont Medical Products Pty Ltd., Vapotherm, Inc., Masimo Corporation, Dragerwerk AG & Co. KGaA, BMC Medical Co., Ltd., Heka Medicals India Private Limited, Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, Well Lead Medical Co., Ltd., Vyaire Medical, Inc., Narang Medical Limited, Teleflex Incorporated, MEKICS Co., Ltd., Great Group Medical Co., Ltd., Allied Medical Limited, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, Synergy Intact Private Limited, nice Neotech Medical Systems Pvt. Ltd., and Sterimed Group.

Market Segmentation & Coverage

This research report categorizes the High-flow Nasal Cannula Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit, and Nasal Cannula.
  • Based on Indication, market is studied across Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis, Carbon Monoxide Toxicity, and Chronic Obstructive Pulmonary Disease.
  • Based on End User, market is studied across Ambulatory Care Centers, Hospitals, and Long-Term Care Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
      • 5.1.1.2. Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
      • 5.1.1.3. Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively High Cost Compared to Traditional Cannula
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in High-Flow Nasal Cannula
      • 5.1.3.2. Favorable Regulatory Framework Supporting Commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
    • 5.2.2. End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. High-flow Nasal Cannula Market, by Component

  • 6.1. Introduction
  • 6.2. Active Humidifier
  • 6.3. Air Oxygen Blender
  • 6.4. Heated Inspiratory Circuit
  • 6.5. Nasal Cannula

7. High-flow Nasal Cannula Market, by Indication

  • 7.1. Introduction
  • 7.2. Acute Heart Failure
  • 7.3. Acute Respiratory Failure
  • 7.4. Bronchiectasis
  • 7.5. Carbon Monoxide Toxicity
  • 7.6. Chronic Obstructive Pulmonary Disease

8. High-flow Nasal Cannula Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Hospitals
  • 8.4. Long-Term Care Centers

9. Americas High-flow Nasal Cannula Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific High-flow Nasal Cannula Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa High-flow Nasal Cannula Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies
    • 12.3.2. Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System
    • 12.3.3. Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness

Companies Mentioned

  • 1. SunMed, LLC
  • 2. Flexicare (Group) Limited
  • 3. ResMed, Inc.
  • 4. Armstrong Medical Limited
  • 5. ICU Medical, Inc.
  • 6. Fairmont Medical Products Pty Ltd.
  • 7. Vapotherm, Inc.
  • 8. Masimo Corporation
  • 9. Dragerwerk AG & Co. KGaA
  • 10. BMC Medical Co., Ltd.
  • 11. Heka Medicals India Private Limited
  • 12. Koninklijke Philips N.V.
  • 13. Fisher & Paykel Healthcare Corporation Limited
  • 14. Well Lead Medical Co., Ltd.
  • 15. Vyaire Medical, Inc.
  • 16. Narang Medical Limited
  • 17. Teleflex Incorporated
  • 18. MEKICS Co., Ltd.
  • 19. Great Group Medical Co., Ltd.
  • 20. Allied Medical Limited
  • 21. Guangdong Pigeon Medical Apparatus Co.,Ltd.
  • 22. Hamilton Medical AG
  • 23. Synergy Intact Private Limited
  • 24. nice Neotech Medical Systems Pvt. Ltd.
  • 25. Sterimed Group

LIST OF FIGURES

  • FIGURE 1. HIGH-FLOW NASAL CANNULA MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH-FLOW NASAL CANNULA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH-FLOW NASAL CANNULA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH-FLOW NASAL CANNULA MARKET DYNAMICS
  • TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023